Abstract:Background: Candida auris ( C. auris ), a recently developing fungal disease with high virulence, easy transmission, and substantial medication resistance in hospitals, poses a growing danger to human health. In 2009, the initial documentation of this disease was made when it was discovered in the ear canal of an elderly Japanese patient. Since its initial isolation, the presence of C. auris across six continents has been a cause for severe concern among medical professionals and scientists. According to recent findings, C. auris is connected with five geographically different lineages and significant rates of antifungal resistance. Furthermore, C. auris infections in healthcare settings lack appropriate treatment options and standardized strategies for prevention and control. This results in many treatment failures and hinders the elimination of C. auris in healthcare institutions. To examine the drug resistance mechanism of C. auris and to aid in clinical therapy, we provide a case of C. auris infection along with a short review of the relevant literature. Clinical presentation: An 81-year-old female with cerebral hemorrhage was admitted to the hospital and diagnosed with a urinary catheter-related C. auris . The sample was evaluated and reported in terms of culture, identification, drug sensitivity, and gene sequencing. We also evaluated the relationship between the morphology of the isolated strains and their drug resistance. Whole-genome sequencing yielded the genes ERG11-Y132F, CDR1-E709D, TAC1B-Q503E, and TAC1B-A583S; however, no additional loci included alterations of concern, according to our results. ERG11-Y132F and TAC1B-A583S are drug-resistant gene loci, whereas CDR1-E709D and TAC1B-Q503E are unidentified variants. Conclusion: We discover a C. auris case of specific a strain in an old female that has some drug-resistant genes, and some genes may be different from already reported gene sites. Gene locus, mutation, and drug resistance mechanism studies may contribute to the creation of innovative drugs and therapeutic treatments. Clinicians and microbiologists must be aware of this globally spreading yeast, which poses substantial hospital diagnostic, treatment, and infection control challenges. Future multicenter research must be performed to uncover this health threat and provide new, effective treatments.

Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Candida auris-associated hospitalizations and outbreaks, China, 2018–2023

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Candida auris infections in China

Alert to the emergence of the "super fungus" infection in China

First two fungemia cases caused by Candida haemulonii var. vulnera in China with emerged antifungal resistance

Two outbreaks and sporadic occurrences of Candida auris from one hospital in China: an epidemiological, genomic retrospective study

A Case of Candida Auris Candidemia in Xiamen, China, and a Comparative Analysis of Clinical Isolates in China

Resistance and virulence genes characteristic of a South Asia Clade (I) Candida auris strain isolated from blood in Beijing

Clinical and Microbiological Investigation of Fungemia from Four Hospitals in China

A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of Candida auris isolated from Beijing, China

Emerging trends of invasive yeast infections and azole resistance in Beijing intensive care units

Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

The First Isolate of Candida Auris in China: Clinical and Biological Aspects

High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: An ignored matter of concern

Surveillance of resistance to fluconazole and voriconazole in Candida isolates from 5 hospitals in China

Candida auris infection; diagnosis, and resistance mechanism using high-throughput sequencing technology: a case report and literature review

Genomic Epidemiology of Candida Auris in a General Hospital in Shenyang, China: a Three-Year Surveillance Study.

Clonal Dissemination of Antifungal- Resistant<i> Candida</i><i> haemulonii,</i> China

First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China